Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nathaniel J Buteyn"'
Autor:
William E. Carson, Isaac Rampersaud, Casey Ren, Vedat O. Yildiz, Charles E. Moritz, David Albertson, Steven Sun, Nicholas B. Courtney, Tiffany Noel, Arfaan Rampersaud, Nathaniel J Buteyn, Jonathan P. Butchar, Lorena P. Suarez-Kelly, Lianbo Yu, Megan C. Duggan, Susheela Tridandapani
Publikováno v:
ACS Appl Nano Mater
Background fluorescent nanodiamonds (FND) are nontoxic, infinitely photostable nanoparticles that emit near-infrared fluorescence and have a modifiable surface allowing for the generation of protein-FND conjugates. FND-mediated immune cell targeting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2cbf9b77ee0aeb354ce10fb3f6a03be
https://doi.org/10.1021/acsanm.1c00256
https://doi.org/10.1021/acsanm.1c00256
Autor:
Anasuya Sarkar, Rakesh A Murugesan, Giovanna Merchand-Reyes, John C. Byrd, Sumithira Vasu, Jonathan P. Butchar, Susheela Tridandapani, Gino M Dettorre, Bethany L. Mundy-Bosse, Nathaniel J Buteyn, Ramasamy Santhanam
Publikováno v:
J Immunol
TLRs, a family of membrane-bound pattern recognition receptors found on innate immune cells, have been well studied in the context of cancer therapy. Activation of these receptors has been shown to induce inflammatory anticancer events, including dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31e812daf9c29557dc853759fb99c7de
https://doi.org/10.4049/jimmunol.1900885
https://doi.org/10.4049/jimmunol.1900885
Autor:
Jillian Konyndyk, Jonathan Knott, Jenna C. Tenney, Ye In Oh, Herb Fynewever, Nathaniel J Buteyn, David Koetje, Amy M. Wilstermann, Paige Bokach
Publikováno v:
The American Biology Teacher. 81:176-185
An introductory cell biology laboratory course was redesigned using two inquiry-based modules to align with the goals of scientific inquiry as described in Vision and Change. To evaluate the lab's efficacy, we used a broad range of materials, includi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3f4d36a247d2ea473a9259e9c4b99a3
https://doi.org/10.1525/abt.2019.81.3.176
https://doi.org/10.1525/abt.2019.81.3.176
Autor:
Hafza Inshaar, Giovanna Merchand-Reyes, Nathaniel J Buteyn, Kavin Fatehchand, Christopher B Colvin, Xiaokui Mo, Brenda Shen, Jonathan P. Butchar, Susheela Tridandapani, Bethany L. Mundy-Bosse, Payal Mehta, Ramasamy Santhanam
Publikováno v:
Oncotarget
Acute myeloid leukemia (AML) is characterized by the proliferation of immature myeloid blasts and a suppressed immune state. Interferons have been previously shown to aid in the clearance of AML cells. Type I interferons are produced primarily by pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51a0686ef557260cac326d12c98c43d9
https://pubmed.ncbi.nlm.nih.gov/33953842
https://pubmed.ncbi.nlm.nih.gov/33953842
Autor:
Shalini Gautam, Jonathan P. Butchar, Susheela Tridandapani, Kavin Fatehchand, William E. Carson, Gino M Dettorre, Giovanna Merchand-Reyes, John C. Byrd, Sumithira Vasu, Bonnie K. Harrington, Ramasamy Santhanam, Sally E. Henderson, Don M. Benson, Huiqing Fang, Xiaokui Mo, Nathaniel J Buteyn
Acute myeloid leukemia (AML) remains a significant health problem, with poor outcomes despite chemotherapy and bone marrow transplants. Although one form of AML, acute promyelocytic leukemia (APL), is successfully treated with all-trans retinoic acid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0778cf37515e229f69cf8c4214436842
https://europepmc.org/articles/PMC6059202/
https://europepmc.org/articles/PMC6059202/
Autor:
Brenda F. Reader, Elizabeth L. McMichael, Nathaniel J Buteyn, Saranya Elavazhagan, Susheela Tridandapani, James S. Blachly, Kavin Fatehchand, Payal Mehta, Shalini Gautam, Jonathan P. Butchar, Huiqing Fang, William E. Carson, Don M. Benson, Giovanna Merchand-Reyes, John C. Byrd, Sumithira Vasu, Xiaokui Mo, Ramasamy Santhanam
Publikováno v:
The Journal of biological chemistry. 291(49)
Acute myeloid leukemia (AML) is characterized by the proliferation of immature myeloid lineage blasts. Due to its heterogeneity and to the high rate of acquired drug resistance and relapse, new treatment strategies are needed. Here, we demonstrate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d5470e3f3c24ea6fc4cead398da7da
https://pubmed.ncbi.nlm.nih.gov/27780867
https://pubmed.ncbi.nlm.nih.gov/27780867